METHODS FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION WITH ACTIVIN RECEPTOR PROTEINS TYPE IIA (ACTRIIA) AND / OR THEIR VARIANTS
PE0016922026A1Pending Publication Date: 2026-08-19MERCK SHARP & DOHME LLC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- PE2026001816
- Authority / Receiving Office
- PE · PE
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2024-12-05
- Filing Date
- 2024-12-05
- Publication Date
- 2026-08-19
Abstract
The present invention relates to a human ActRIIA-Fc fusion protein or a variant thereof, which enables the treatment of pulmonary arterial hypertension. The invention also relates to a method of treatment for said disease.
Need to check novelty before this filing date? Find Prior Art